Standard BioTools Inc (LAB)
1.925
0.00 (0.00%)
USD |
NASDAQ |
Jun 21, 16:00
1.925
0.00 (0.00%)
After-Hours: 20:00
Standard BioTools Cash from Operations (Quarterly): -62.48M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -62.48M |
| December 31, 2023 | -14.06M |
| September 30, 2023 | -11.41M |
| June 30, 2023 | -9.329M |
| March 31, 2023 | -8.485M |
| December 31, 2022 | -19.18M |
| September 30, 2022 | -24.61M |
| June 30, 2022 | -29.99M |
| March 31, 2022 | -15.59M |
| December 31, 2021 | -7.002M |
| September 30, 2021 | -9.494M |
| June 30, 2021 | -14.66M |
| March 31, 2021 | -12.90M |
| December 31, 2020 | -3.733M |
| September 30, 2020 | -4.599M |
| June 30, 2020 | -2.79M |
| March 31, 2020 | -4.295M |
| December 31, 2019 | -5.519M |
| September 30, 2019 | -4.548M |
| June 30, 2019 | -5.013M |
| March 31, 2019 | -20.13M |
| December 31, 2018 | -0.638M |
| September 30, 2018 | -4.064M |
| June 30, 2018 | -4.323M |
| March 31, 2018 | -16.18M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.661M |
| September 30, 2017 | -7.981M |
| June 30, 2017 | -8.29M |
| March 31, 2017 | -8.488M |
| December 31, 2016 | -10.73M |
| September 30, 2016 | -13.26M |
| June 30, 2016 | -7.354M |
| March 31, 2016 | -7.792M |
| December 31, 2015 | -4.404M |
| September 30, 2015 | -12.70M |
| June 30, 2015 | -7.829M |
| March 31, 2015 | -9.80M |
| December 31, 2014 | -3.525M |
| September 30, 2014 | -8.863M |
| June 30, 2014 | 0.312M |
| March 31, 2014 | -10.55M |
| December 31, 2013 | 3.238M |
| September 30, 2013 | -1.308M |
| June 30, 2013 | -2.637M |
| March 31, 2013 | -0.884M |
| December 31, 2012 | -3.499M |
| September 30, 2012 | -3.336M |
| June 30, 2012 | -4.00M |
| March 31, 2012 | -6.643M |
| December 31, 2011 | -2.255M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-62.48M
Minimum
Mar 2024
-2.79M
Maximum
Jun 2020
-13.48M
Average
-9.412M
Median
Cash from Operations (Quarterly) Benchmarks
| Bruker Corp | 21.80M |
| Azenta Inc | 8.356M |
| Harvard Bioscience Inc | 1.403M |
| Bionano Genomics Inc | -28.13M |
| Akoya Biosciences Inc | -20.82M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 318.08M |
| Cash from Financing (Quarterly) | -19.73M |
| Free Cash Flow | -99.88M |
| Free Cash Flow Per Share (Quarterly) | -0.2151 |
| Free Cash Flow to Equity (Quarterly) | -54.70M |
| Free Cash Flow to Firm (Quarterly) | -63.26M |
| Free Cash Flow Yield | -39.03% |